KNTPF
Price:
$0.216
Market Cap:
$789.55M
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in developing and commercializing a pipeline of small molecule and biological therapeutics for androgen-receptor-related disease areas with unmet medical needs in the People's Republic of China and internationally. The company's products pipeline include Proxalutamide, a second generation androgen receptor (AR) antagonist for the treatment of metastatic castration-resistant prostate cancer, AR positive breast cancer, and COVID-19; and Pyrilutamide, an AR antagonist for the androgenetic alopecia (AGA) and acne vulgaris treatment. Its products pipeline also comprise ALK-1 antibody for the treatment of metastatic hep...[Read more]
Industry
Biotechnology
IPO Date
2020-12-11
Stock Exchange
OTC
Ticker
KNTPF
According to Kintor Pharmaceutical Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 824.09M. This represents a change of 177.22% compared to the average of 297.27M of the last 4 quarters.
The mean historical Enterprise Value of Kintor Pharmaceutical Limited over the last ten years is 2.68B. The current 824.09M Enterprise Value has changed 2.97% with respect to the historical average. Over the past ten years (40 quarters), KNTPF's Enterprise Value was at its highest in in the June 2021 quarter at 17.18B. The Enterprise Value was at its lowest in in the December 2018 quarter at -67870000.00.
Average
2.68B
Median
2.90B
Minimum
377.99M
Maximum
4.47B
Discovering the peaks and valleys of Kintor Pharmaceutical Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 49.04%
Maximum Annual Enterprise Value = 4.47B
Minimum Annual Increase = -83.46%
Minimum Annual Enterprise Value = 377.99M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 377.99M | -15.25% |
| 2023 | 446.02M | -83.46% |
| 2022 | 2.70B | -3.68% |
| 2021 | 2.80B | 49.04% |
| 2020 | 1.88B | -57.94% |
| 2019 | 4.47B | 10.20% |
| 2018 | 4.05B | 16.04% |
| 2017 | 3.49B | -3.02% |
| 2016 | 3.60B | 19.96% |
| 2015 | 3.00B | 19.45% |
The current Enterprise Value of Kintor Pharmaceutical Limited (KNTPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.17B
5-year avg
1.64B
10-year avg
2.68B
Kintor Pharmaceutical Limited’s Enterprise Value is greater than Paradigm Biopharmaceuticals Limited (127.34M), greater than Poolbeg Pharma PLC (15.97M), greater than Nuo Therapeutics, Inc. (108.26M), greater than Hofseth BioCare ASA (562.31M), greater than Imugene Limited (81.08M), greater than Satellos Bioscience Inc. (41.10M), greater than Scancell Holdings plc (101.59M), greater than Shield Therapeutics plc (136.75M), greater than VitaSpring Biomedical Co. Ltd. (207.39M), greater than Innate Pharma S.A. (128.18M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 127.34M | $109.88M | |
| 15.97M | $29.63M | |
| 108.26M | $108.66M | |
| 562.31M | $66.68M | |
| 81.08M | $57.72M | |
| 41.10M | $87.00M | |
| 101.59M | $140.10M | |
| 136.75M | $95.67M | |
| 207.39M | $207.03M | |
| 128.18M | $183.43M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kintor Pharmaceutical Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kintor Pharmaceutical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Kintor Pharmaceutical Limited's Enterprise Value?
What is the highest Enterprise Value for Kintor Pharmaceutical Limited (KNTPF)?
What is the 3-year average Enterprise Value for Kintor Pharmaceutical Limited (KNTPF)?
What is the 5-year average Enterprise Value for Kintor Pharmaceutical Limited (KNTPF)?
How does the current Enterprise Value for Kintor Pharmaceutical Limited (KNTPF) compare to its historical average?